April 23, 2014 10:03 PM ET


Company Overview of Eureka Therapeutics, Inc.

Executive Profile

Chih-Kai Cheng

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Mr. C. K. Cheng is the Co-founder and General Partner of Harbinger III Venture Capital, a pan-Pacific venture capital firm actively investing in US, Taiwan, and China. Prior to founding Harbinger III Venture Capital in 2000 with the anchor investment from MiTAC/Synnex Group, Mr. Cheng served as Senior Vice President of Product Marketing at Synnex (NYSE:SNX). During his 8-year tenure with Synnex, he held various management responsibilities including product line management, ...

Corporate Headquarters

5858 Horton Street
Emeryville, California 94608

United States

Phone: 510-654-7045
Fax: 510-654-7077

Board Members Memberships

Former Director


National Chiao Tung University
National Tsing-hua University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$1,800
Total Calculated Compensation$1,800

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Hong Q. Hou Ph.D.Chief Executive Officer, President and Director
EMCORE Corporation
Gregory P. Dougherty Chief Executive Officer and Director
Oclaro, Inc.
Timothy Storrs Jenks Chairman of The Board, Chief Executive Officer and President
NeoPhotonics Corporation
Hideo Yagi President and Representative Director
Yagi & Co., Ltd.
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Eureka Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.